Last reviewed · How we verify
Inotropes
At a glance
| Generic name | Inotropes |
|---|---|
| Also known as | saline |
| Sponsor | Amsterdam UMC, location VUmc |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- GLS in Difficult CPB Weaning
- Cerebral Oxygen Saturation Monitoring In Cardiac Surgery (COSMICS) (NA)
- Hypotension Prediction Index (HPI) and Assisted Fluid Management (AFM) for Perioperative Hemodynamic Optimization in Patients Under General Anesthesia (NA)
- Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock (NA)
- Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot Study (NA)
- Levosimendan in Acute Decompensated Heart Failure (PHASE2, PHASE3)
- Genomic Determinants of Outcome in Cardiogenic Shock
- Observational Prospective Transesophageal Myocardial Ultrasound Survey
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inotropes CI brief — competitive landscape report
- Inotropes updates RSS · CI watch RSS
- Amsterdam UMC, location VUmc portfolio CI